J Am Acad Dermatol:三种筛查工具有助于诊断银屑病性关节炎

2014-08-01 Elizabeth(编译) 睿医资讯

通常,银屑病发生于PsA前,医生需警惕银屑病患者发生关节炎的可能性。PsA获得充分治疗的时间越晚,患者发生不可逆的关节损伤及其他改变的可能性越大。医生需要一种高度敏感的问卷表以对患者进行筛查以对潜在PsA患者进行评估。新的研究指出,有三种筛查工具可帮助诊断银屑病性关节炎(PsA),保证患者可及时接受治疗。 来自华盛顿大学和西雅图瑞典医学中心的Philip J. Mease及其研究组评估了3种

通常,银屑病发生于PsA前,医生需警惕银屑病患者发生关节炎的可能性。PsA获得充分治疗的时间越晚,患者发生不可逆的关节损伤及其他改变的可能性越大。医生需要一种高度敏感的问卷表以对患者进行筛查以对潜在PsA患者进行评估。新的研究指出,有三种筛查工具可帮助诊断银屑病性关节炎(PsA),保证患者可及时接受治疗。

来自华盛顿大学和西雅图瑞典医学中心的Philip J. Mease及其研究组评估了3种可在诊室中应用的工具——银屑病和关节炎筛查问卷(Psoriasis and Arthritis Screening Questionnaire,PASQ)、银屑病流行病学筛查工具(Psoriasis Epidemiology Screening Tool,PEST)、多伦多PsA筛查表(Toronto PsA Screen,ToPAS)。研究显示,这3种筛查方法在分辨PsA和非PsA患者时都表现出良好的敏感性和特异性。

Dr. Mease及其同事对估算PsA患病率的PREPARE试验的数据进行了亚研究,重点关注了PREPARE试验中所使用的3种筛查问卷的效果。相关结果6月25日在线发表于《美国皮肤病学会期刊(Journal of the American Academy of Dermatology)》。

除筛查问卷外,患者还接受了风湿病学家的评估。研究者们通过比较两种方式获得诊断来评估问卷的准确性,并计算了其敏感性/特异性以及阳性/阴性预测值。

在949例银屑病患者中,风湿病学家诊断有285例(30%)患有临床PsA。

而使用PASQ、PEST和ToPAS问卷进行筛查,结果发现可能患有PsA的患者比例分别为45.1%、43.0%和42.9%。三者的敏感/特异度、阳性/阴性预测值如下:


研究所使用的3种筛查工具均有很好的效果。使用这3种工具可分辨出PsA可能性较高的患者,这提示需由风湿病学医师进一步对此类患者进行评估。还需注意的是,3种筛查工具的阴性预测值均较高,提示这3种方法可分辨出患PsA可能性较小的患者,这些患者无需进行进一步评估。

在筛查工具的选择方面,来自芝加哥西北大学费恩伯格医学院的Eric M. Ruderman认为,重要的是使用其中一种筛查手段,而不是顾虑哪种方法最好。审视本项研究评估的筛查工具,确定哪种方法最适合你的实践流程,然后开始应用。

也有专家表示,这3种筛查手段都不尽完美。很多银屑病患者因其他原因而具有关节或后背疼痛,这3种筛查方法的特异性都不足以鉴别这些疼痛。

但增强皮肤科医师对于这一情况的认识,常规合理使用这3种筛查工具或许是可以实现的,这也可尽早诊断并获得更好的预后。

原始出处:

Mease PJ1, Gladman DD2, Helliwell P3, Khraishi MM4, Fuiman J5, Bananis E5, Alvarez D5.Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.J Am Acad Dermatol. 2014 Jun 25. pii: S0190-9622(14)01438-8. doi: 10.1016/j.jaad.2014.05.010. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655109, encodeId=8c9116551096a, content=<a href='/topic/show?id=aa1fe59284f' target=_blank style='color:#2F92EE;'>#筛查工具#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75928, encryptionId=aa1fe59284f, topicName=筛查工具)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ef224632617, createdName=jwf_2009, createdTime=Wed Aug 27 10:30:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740754, encodeId=f0d31e40754fd, content=<a href='/topic/show?id=99b09663e61' target=_blank style='color:#2F92EE;'>#银屑病性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96637, encryptionId=99b09663e61, topicName=银屑病性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a4934807424, createdName=41514498@qq.com, createdTime=Mon Apr 13 07:30:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651808, encodeId=251b1651808d1, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu May 14 16:30:00 CST 2015, time=2015-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265217, encodeId=3095126521e4a, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 03 01:30:00 CST 2014, time=2014-08-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655109, encodeId=8c9116551096a, content=<a href='/topic/show?id=aa1fe59284f' target=_blank style='color:#2F92EE;'>#筛查工具#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75928, encryptionId=aa1fe59284f, topicName=筛查工具)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ef224632617, createdName=jwf_2009, createdTime=Wed Aug 27 10:30:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740754, encodeId=f0d31e40754fd, content=<a href='/topic/show?id=99b09663e61' target=_blank style='color:#2F92EE;'>#银屑病性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96637, encryptionId=99b09663e61, topicName=银屑病性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a4934807424, createdName=41514498@qq.com, createdTime=Mon Apr 13 07:30:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651808, encodeId=251b1651808d1, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu May 14 16:30:00 CST 2015, time=2015-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265217, encodeId=3095126521e4a, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 03 01:30:00 CST 2014, time=2014-08-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1655109, encodeId=8c9116551096a, content=<a href='/topic/show?id=aa1fe59284f' target=_blank style='color:#2F92EE;'>#筛查工具#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75928, encryptionId=aa1fe59284f, topicName=筛查工具)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ef224632617, createdName=jwf_2009, createdTime=Wed Aug 27 10:30:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740754, encodeId=f0d31e40754fd, content=<a href='/topic/show?id=99b09663e61' target=_blank style='color:#2F92EE;'>#银屑病性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96637, encryptionId=99b09663e61, topicName=银屑病性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a4934807424, createdName=41514498@qq.com, createdTime=Mon Apr 13 07:30:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651808, encodeId=251b1651808d1, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu May 14 16:30:00 CST 2015, time=2015-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265217, encodeId=3095126521e4a, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 03 01:30:00 CST 2014, time=2014-08-03, status=1, ipAttribution=)]
    2015-05-14 lishizhe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1655109, encodeId=8c9116551096a, content=<a href='/topic/show?id=aa1fe59284f' target=_blank style='color:#2F92EE;'>#筛查工具#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75928, encryptionId=aa1fe59284f, topicName=筛查工具)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ef224632617, createdName=jwf_2009, createdTime=Wed Aug 27 10:30:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740754, encodeId=f0d31e40754fd, content=<a href='/topic/show?id=99b09663e61' target=_blank style='color:#2F92EE;'>#银屑病性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96637, encryptionId=99b09663e61, topicName=银屑病性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a4934807424, createdName=41514498@qq.com, createdTime=Mon Apr 13 07:30:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651808, encodeId=251b1651808d1, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu May 14 16:30:00 CST 2015, time=2015-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265217, encodeId=3095126521e4a, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 03 01:30:00 CST 2014, time=2014-08-03, status=1, ipAttribution=)]
    2014-08-03 lmm397

相关资讯

Lancet:ustekinumab治疗银屑病性关节炎有效

银屑病是一种免疫介导的炎性疾病,约有20%的银屑病患者会存在血清阴性的关节炎,即银屑病性关节炎。银屑病患者的疾病负担较大,在合并关节炎时尤甚。环境因素和个体的遗传易感性的共同作用是银屑病和银屑病性关节炎的发病基础。来自全基因组关联扫描的数据证实存在一些共有的遗传基因易感位点,包括白介素12和23中所包含的单核苷酸多态性,从而导致各种障碍之间存在一定重叠部分。然而,因为目前的研究几乎不会关注皮肤和关